Freenome

Freenome

Biotechnology, 259 E Grand Ave Ste 3434, South San Francisco, California, 94080, United States, 201-500 Employees

freenome.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 83********

Who is FREENOME

Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease. To achieve this mission, Freenome is d...

Read More

map
  • 259 E Grand Ave Ste 3434, South San Francisco, California, 94080, United States Headquarters: 259 E Grand Ave Ste 3434, South San Francisco, California, 94080, United States
  • 2014 Date Founded: 2014
  • 201-500 Employees: 201-500
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2835 | NAICS Code: 541720 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from FREENOME

Freenome Org Chart and Mapping

Employees

Jackie Moriarty

Director of Market Development

Prashant Subedi

Senior Research Associate

Michael Pearson

Manager and Senior Development Scientist

Jeremy Primus

Computational Biologist II, Assay Development

Mike Molmen

Director of Market Development

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Freenome

Answer: Freenome's headquarters are located at 259 E Grand Ave Ste 3434, South San Francisco, California, 94080, United States

Answer: Freenome's phone number is 83********

Answer: Freenome's official website is https://freenome.com

Answer: Freenome's revenue is $1 Million to $5 Million

Answer: Freenome's SIC: 2835

Answer: Freenome's NAICS: 541720

Answer: Freenome has 201-500 employees

Answer: Freenome is in Biotechnology

Answer: Freenome contact info: Phone number: 83******** Website: https://freenome.com

Answer: Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease. To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas. We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Societys BrightEdge Ventures. A Freenomer is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients' lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access